Strader D B, Benjamin S B, Orbuch M, Lubensky T A, Gibril F, Weber C, Fishbeyn V A, Jensen R T, Metz D C
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Digestion. 1995;56(5):347-56. doi: 10.1159/000201258.
Manifestations of esophageal disease are present in up to 60% of patients with Zollinger-Ellison syndrome (ZES), although esophageal function has been studied in only a few patients and the prevalence of Barrett's mucosa is unknown in these patients. It is unclear whether the high prevalence of esophageal disease is related to gastric acid hypersecretion alone or to abnormalities of esophageal motility or lower esophageal sphincter (LES) function in addition. To address these issues in the present study esophageal function was evaluated prospectively in 92 consecutive patients with ZES (66 with active disease, 26 disease-free after curative resection) seen during a 1-year period after controlling acid hypersecretion. In the patients with active disease the mean basal acid output (BAO) was 33 +/- 3.0 mEq/h, the maximal acid output (MAO) was 56 +/- 4.0 mEg/h, fasting serum gastrin was 8,736 +/- 4,813 pg/ml and duration of disease prior to study was 12.5 +/- 2.0 years. At the time of manometry, gastric acid secretion was controlled in all patients and no patient had evidence of gastroesophageal reflux disease at upper gastrointestinal endoscopy. Esophageal manometry revealed normal motility in 85% of patients. Eleven percent had low LES pressures, and only 1% of patients had an elevated LES pressure. The frequency of Barrett's mucosa (3%) was similar to that found in the general population but much less than that reported in patients with idiopathic GERD. No correlation was noted between LES pressures or manometric abnormalities and the fasting serum gastrin, BAO, MAO or the presence or absence of multiple endocrine neoplasia type I or previous vagotomy. Esophageal manometric results and LES pressure were similar in disease-free patients and those with active ZES. In conclusion, these results suggest that hypergastrinemia or other disease-specific abnormalities are not contributing to the high incidence of esophageal disease in patients with ZES because esophageal function in patients with ZES is similar to normals. Specifically, motility disorders in patients with ZES occur in similar frequency to normals, and LES pressure is normal in most patients. Despite the high levels of acid secretion and prominence of symptoms, the occurrence of Barrett's mucosa was uncommon (3%) raising the possibility of additional protective mechanisms in patients with ZES.
在卓-艾综合征(ZES)患者中,高达60%存在食管疾病表现,尽管仅对少数患者的食管功能进行过研究,且这些患者中Barrett黏膜的患病率尚不清楚。目前尚不清楚食管疾病的高患病率是仅与胃酸分泌过多有关,还是还与食管动力异常或食管下括约肌(LES)功能异常有关。为了解决这些问题,在本研究中,对92例连续的ZES患者(66例患有活动性疾病,26例在根治性切除术后无病)进行了前瞻性食管功能评估,这些患者是在控制胃酸分泌过多后的1年期间内就诊的。在患有活动性疾病的患者中,平均基础酸排量(BAO)为33±3.0 mEq/h,最大酸排量(MAO)为56±4.0 mEq/h,空腹血清胃泌素为8736±4813 pg/ml,研究前疾病持续时间为12.5±2.0年。在进行食管测压时,所有患者的胃酸分泌均得到控制,且在上消化道内镜检查中没有患者有胃食管反流病的证据。食管测压显示85%的患者食管动力正常。11%的患者LES压力低,只有1%的患者LES压力升高。Barrett黏膜的发生率(3%)与普通人群相似,但远低于特发性胃食管反流病患者的报道。未发现LES压力或测压异常与空腹血清胃泌素、BAO、MAO或是否存在多发性内分泌肿瘤I型或既往迷走神经切断术之间存在相关性。无病患者和患有活动性ZES的患者的食管测压结果和LES压力相似。总之,这些结果表明,高胃泌素血症或其他疾病特异性异常并非导致ZES患者食管疾病高发的原因,因为ZES患者的食管功能与正常人相似。具体而言,ZES患者的动力障碍发生率与正常人相似,且大多数患者的LES压力正常。尽管胃酸分泌水平高且症状突出,但Barrett黏膜的发生率并不常见(3%),这增加了ZES患者存在其他保护机制的可能性。